Procter & Gamble Health Limited (NSE:PGHL)
India · Delayed Price · Currency is INR 6,287.00
+80.00 (1.29%)
Jun 12, 2026, 3:30 PM IST
Procter & Gamble Health Market Cap
Procter & Gamble Health has a market cap or net worth of 104.14 billion as of June 12, 2026. Its market cap has increased by 15.97% in one year.
Market Cap
104.14B
Enterprise Value
102.38B
Revenue
14.08B
Ranking
n/a
PE Ratio
31.85
Stock Price
6,287.00
Market Cap Chart
Since June 14, 1999, Procter & Gamble Health's market cap has increased from 9.75B to 104.14B, an increase of 968.53%. That is a compound annual growth rate of 9.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 12, 2026 | 104.14B | 10.04% |
| Dec 31, 2025 | 94.63B | 8.85% |
| Dec 31, 2024 | 86.94B | 5.90% |
| Dec 29, 2023 | 82.10B | 23.12% |
| Dec 30, 2022 | 66.69B | -24.14% |
| Dec 31, 2021 | 87.91B | -22.28% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eris Lifesciences | 194.63B |
| Cohance Lifesciences | 163.34B |
| NATCO Pharma | 154.73B |
| Alembic Pharmaceuticals | 146.12B |
| Alivus Life Sciences | 128.35B |
| Strides Pharma Science | 97.29B |
| Akums Drugs and Pharmaceuticals | 95.37B |
| Sudeep Pharma | 84.65B |